.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Queensland Health
Dow
Fuji
Accenture
Merck
McKinsey
Boehringer Ingelheim
Julphar
Moodys

Generated: June 25, 2017

DrugPatentWatch Database Preview

Ferric carboxymaltose - Generic Drug Details

« Back to Dashboard

What are the generic sources for ferric carboxymaltose and what is the scope of ferric carboxymaltose patent protection?

Ferric carboxymaltose
is the generic ingredient in one branded drug marketed by Luitpold Pharms Inc and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Ferric carboxymaltose has fifty-five patent family members in thirty countries.

There are fourteen drug master file entries for ferric carboxymaltose. One supplier is listed for this compound.

Summary for Generic Name: ferric carboxymaltose

Tradenames:1
Patents:5
Applicants:1
NDAs:1
Drug Master File Entries: see list14
Suppliers / Packagers: see list1
Clinical Trials: see list132
Drug Prices:see low prices
DailyMed Link:ferric carboxymaltose at DailyMed

Pharmacology for Ingredient: ferric carboxymaltose

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Luitpold Pharms Inc
INJECTAFER
ferric carboxymaltose
INJECTABLE;INTRAVENOUS203565-001Jul 25, 2013RXYesYes7,612,109► SubscribeYY ► Subscribe
Luitpold Pharms Inc
INJECTAFER
ferric carboxymaltose
INJECTABLE;INTRAVENOUS203565-001Jul 25, 2013RXYesYes► Subscribe► Subscribe
Luitpold Pharms Inc
INJECTAFER
ferric carboxymaltose
INJECTABLE;INTRAVENOUS203565-001Jul 25, 2013RXYesYes7,754,702► SubscribeY ► Subscribe
Luitpold Pharms Inc
INJECTAFER
ferric carboxymaltose
INJECTABLE;INTRAVENOUS203565-001Jul 25, 2013RXYesYes8,895,612► SubscribeY ► Subscribe
Luitpold Pharms Inc
INJECTAFER
ferric carboxymaltose
INJECTABLE;INTRAVENOUS203565-001Jul 25, 2013RXYesYes9,376,505► SubscribeYY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: ferric carboxymaltose

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,431,549Methods and compositions for administration of iron► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: ferric carboxymaltose

Country Document Number Estimated Expiration
European Patent Office1973549► Subscribe
Russian Federation2303039► Subscribe
Germany50313653► Subscribe
Hong Kong1125044► Subscribe
Norway333008► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Fuji
Express Scripts
QuintilesIMS
Julphar
Argus Health
UBS
Teva
McKesson
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot